Governments around the world consider mushrooms and LSD to be among the most dangerous illicit substances, but a new survey of drug users suggests that these psychedelics are actually some of the safest.
Around 20,000 people reported having used either mushrooms, which contain the psychoactive compound psilocybin, or LSD in the past year, according to the2017 Global Drug Survey. Of those, just over 100 people reported seeking emergency medical treatment related to those drugs. Most of these cases were linked to LSD a total of 1 percent of recent LSD users and just 0.2 percent of recent mushroom users sought treatment.
By that metric, the survey concludes that mushrooms are the safest recreational drug. LSD ranked a close third behind marijuana, as 0.6 percent of people whod used cannabis over the past year reported receiving emergency medical care.
All three drugs were less dangerous than alcohol, which was by far the most widely used intoxicant in the survey and led to 1.3 percent of all recent users seeking emergency treatment. For methamphetamine, the most harmful substance included on the survey,4.8 percent of people whod used in the last year ended up rushing to see a medical professional.
Global Drug Survey
The Global Drug Survey, an independent research company that, since 2014, has partnered with medical experts and media groups to conduct its annual survey, compiled responses from more than 115,000 people in over 50 countries for its 2017 edition. More than 10,000 people from the U.S. responded.
Although drug concerns in the U.S. have centered around heroin and opioids in recent years, the survey suggests these substances are less of a problem elsewhere in the world. Just 2.4 percent of all respondents worldwide reported having used heroin in their lifetime, while 16 percent reported having used prescription painkillers. In the U.S., however, nearly 3 percent of respondents said they used heroin in the past year alone, while 21.2 percent said they used prescription opioids.
The survey underscores key differences between substances. For one, these drugs vary greatly in toxicity. Alcohol, cocaine and synthetic cannabinoids (sometimes called spice or K2) can cause acute harm at relatively low doses, which may lead users to seek treatment to prevent lasting health effects or even death. They are also linked to a number of common secondary health consequences, including injuries from accidents, self-harm or fights.
The typical harm profile of psilocybin and LSD looks a bit different. Its almost impossible to overdose on these drugs alone, though using them with other substances can create more severe interactions. Even on their own, these psychedelics can cause intense episodes of fear, anxiety or disorientation, which may lead users to harm themselves, or to simply decide that they need to seek medical help. Those issues can be compounded among people who have pre-existing mental health conditions like schizophrenia or bipolar disorder.
The surveys findings could say a lot about psychedelics and the way people use them.Theres little evidence of dependence or addiction related to mushrooms or LSD, said Adam Winstock, an addiction psychiatrist and founder of the Global Drug Survey, in an interview with HuffPost. Furthermore,people arent using them just because they think its fun to shroom or dose.
In fact, the survey showed that just 67.5 percent of lifetime users of psychedelics listed recreation or fun as a motivation for tripping. Gaining a deeper understanding of the world, learning more about yourself, mind expansion and curiosity all ranked higher. Another 35.9 percent wanted to deal with emotional issues and slightly more than one-quarter wanted to deal with stress.
Although the survey demonstrates that people use psychedelics for a variety of reasons, the relatively lower rate of purely social or recreational use means they have less overall to exposure to psychedelics than they do to other drugs, said Winstock.
He also pointed to a 2014 survey of psychedelics usersin which respondents reported that they take a number of precautions before tripping.
The second-most important strategy that psychedelic users said they adopted is they dont drive and cycle when theyre on psychedelics, because that would be really dumb, Winstock said. People are more reckless with other drugs, perhaps because they feel more confident about their ability to control their actions and not be so distorted in the way they see the world, but they know that if theyre going to take a trip, they have to have their shit together.
The emergency treatment rate for LSD was a full five times higher than it was for mushrooms, which Winstock said could be because LSD is far more potent and tends to be less predictable. Mushrooms come in a relatively standard dose worldwide a few pieces of fungi. Its not possible to eyeball exactly how much LSD is on a tab or blotter, nor can you tell if its been adulterated with a novel psychedelic substance that could increase the risk of potentially negative or harmful interactions.
Photofusion via Getty Images
In general, however, Winstock suggested that drug users appear to exercise more common sense around psychedelics than they do with other substances.
If people paid as much respect for the planning that they put in place when they take psychedelics, thered probably be a lot less problems with drugs, he said.
This isnt to say that psychedelic trips always go as planned. Just over 5 percent of people whod used mushrooms in their lifetime and 7.6 percent of those whod used LSD said theyd had a difficult or negative experience involving the drug, according to the survey.
But not all bad trips are equal. Although clinical studies of psilocybin use have shown that, in rare cases, these episodes can have troubling long-term effects, users more frequently appear to find themmeaningful or worthwhile.
This only stresses the importance of proper education and preparation, said Winstock.
The 2017 Global Drug Survey adds to a growing body of research that appears to challenge the grounds for the strict, nearly global prohibition on psychedelics. Both U.S. law and United Nations drug treaties hold that mushrooms and LSD have no medical value and a high potential for abuse and harm. But the data largely hasnt supported that position, and emerging science has suggested that the drugs could be used to treat complex psychological conditions, including end-of-life anxiety and addiction.
Inrecent U.S. studieson people suffering from cancer-related anxiety and depression, psilocybin-assisted psychotherapy led to clinically significant reductions in symptoms for between 60 and 80 percent of subjects. Some patients reported that the benefits of a single dose of psilocybin, along with therapy, lasted up to seven months, with minimal side effects. Similar studies using LSD are also underway, though not in the U.S.
Initial studieshave also shown that psilocybin may hold promise in treating alcoholism, building on a rich history of anecdotal evidence that psychedelic drugs, including LSD, could help people battle addiction. The Beckley Foundation, a leading advocate for psychedelic science, is also in the beginning stages of researchinto the effects of LSD microdosing on mood, cognition, productivity and creativity.
Supporters of psychedelics point out that this form of therapy is both controversial and potentially revolutionary because it doesnt focus on treating symptoms. Rather, it holds that some mental illnesses can be addressed by essentially disrupting the default mode network, or ego, of a persons brain, thereby targeting the root cause of the symptoms. In other words, its designed to eliminate the need for treatment, not offer an ongoing one.
Winstock says efforts like the Global Drug Survey prove its time to begin rethinking our approach to psychedelic substances. But he admits there are powerful interests standing in the way of progress, and not all of them are anti-drug government officials.
The reason its taken so long is Big Pharma must be terrified, said Winstock. Ive got patients that have been on antidepressants for years. [Theres a] possibility that you might be able to give someone six sessions of psychedelic-assisted psychotherapy and treat their depression so you dont have to be on Prozac for five years, all with a drug [like psilocybin or LSD] that doesnt have a patent.
Thats a huge threat to the industry, he added, but it makes sense to me.
Go here to see the original:
- This Trippy Oregon Theme Park Is A Low-Key Psychedelic Playground - Thrillist - May 15th, 2020
- EGF Theramed Appoints George Anstey to Board of Directors - Benzinga - May 15th, 2020
- Empower Clinics and EuroLife Brands Close Definitive Agreement and Sign Multi-Year Multi-National Licence Agreement - GuruFocus.com - May 15th, 2020
- Have a Good Trip Demystifies Psychedelics - The New Republic - May 14th, 2020
- Investing in Psychedelics - Energy and Capital - May 14th, 2020
- Psilocybin May be the Key to Treating a Range of Health Issues, Including Obesity - Baystreet.ca - May 14th, 2020
- Movie review: Netflix's 'Have a Good Trip' is only a mild high - Eagle-Tribune - May 14th, 2020
- Psychedelics - Alcohol and Drug Foundation - May 10th, 2020
- Celebrities share LSD trips in Netflix documentary 'Have A Good Trip' - Insider - INSIDER - May 10th, 2020
- The Queen of Consciousness Driving Psychedelic Study and Advocacy - Filter - May 10th, 2020
- The 'Billions' Stock Watch: It's Time For Psychedelics And Subterfuge - UPROXX - May 10th, 2020
- Have a Good Trip: Netflix release and cast as celebrities recall mind-bending experiences - Mirror Online - May 10th, 2020
- From "Solar Opposites" to "Midnight Gospel," recent otherworldly animation is worth the head-trip - Salon - May 10th, 2020
- Netflix Reveals Celebrities' Wildest Drug Trips, From Anthony Bourdain to Carrie Fisher - The Daily Beast - May 10th, 2020
- Psychedelic mushrooms for depression: 'This is the one that changed things' - DW (English) - April 26th, 2020
- MindMed wants to develop a drug to help end a bad LSD trip - Fast Company - April 26th, 2020
- Netflixs The Midnight Gospel Is a Profoundly Weird Psychedelic Trip You Want To Take - Mashable India - April 26th, 2020
- Professor describes uses and history of hallucinogens - The Daily Evergreen - April 26th, 2020
- Media Central moves to provide coverage on emerging Psychedelics and eGames sectors - Proactive Investors USA & Canada - April 26th, 2020
- This video game does the same things to your brain as magic mushrooms - Happy Mag - April 26th, 2020
- Inborn Psychedelia on White Nights' Into the Lap of the Ancient Mother - Invisible Oranges - April 26th, 2020
- Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week - Yahoo Finance - April 9th, 2020
- Psychedelic mushrooms could affect the brain long after its active ingredient leaves the system - The Next Web - April 9th, 2020
- We Could Be Taking Psychedelics to Help Treat Mental Illness in Just Five Years - Newsweek - April 7th, 2020
- Magic mushrooms to treat depression? COMPASS Pathways pushes forward with U.S. patent for psilocybin therapy - Straight.com - April 7th, 2020
- Key Insights from PSYCH: The Psychedelics as Medicine Report - Prohibition Partners - March 18th, 2020
- Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week - Benzinga - March 18th, 2020
- With No Progress in Therapy, NYC Couple Turns to Psychedelics for Help - NBC New York - March 13th, 2020
- Upscale Psychedelics Therapy Center Opens On New Yorks 5th Avenue - Forbes - March 13th, 2020
- Why Kevin O'Leary is betting on psychedelics - Wealth Professional - March 13th, 2020
- Learning the hard way that psychedelic drug use can have long-term consequences - Dailyuw - March 13th, 2020
- Forget taking a pill a day. Canada is using psychedelics to revolutionize the way we treat mental health and addiction - The GrowthOp - March 13th, 2020
- High Stakes: Will The Legalization Of Psychedelics Mimic That Of Cannabis? Will It Learn From Its Mistakes? - Benzinga - March 13th, 2020
- Scientists Just Proved These Two Brain Networks Are Key to Consciousness - Singularity Hub - March 13th, 2020
- Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week - MarketWatch - March 13th, 2020
- Podcast Host Joe Rogan Is Steadily Documenting A Psychedelic Record Of The 21st Century - Forbes - February 27th, 2020
- Empower Clinics to create psilocybin and psychadelics division leveraging corporate wellness and franchise clinic network - Proactive Investors USA... - February 27th, 2020
- The Psilocybin Movement Is Like The Cannabis Movement (Except When It's Not) - Benzinga - February 27th, 2020
- Researchers went to festivals to study psychedelic drugs and found they left people feeling happy and connected hours after the high wore off -... - January 22nd, 2020
- Psychedelics and Their 'Mystical Effects' in the Real World - Medscape - January 22nd, 2020
- Psychedelic Events Are Going Mainstream, Where The Much-Maligned Mushroom Industry Focuses On Mental Health - Forbes - January 18th, 2020
- Psychedelics have 'extraordinarily potent' anti-inflammatory power. Is there a place for them in mainstream medicine? - Genetic Literacy Project - January 18th, 2020
- Silicon Valley Is Micro-Dosing Magic Mushrooms To Boost Their Careers - Forbes - January 18th, 2020
- NYC To Host Economics Of Psychedelics Investing Summit - Benzinga - January 18th, 2020
- The Best FREE Things to Do for the Next Week - My New Orleans - January 18th, 2020
- Photos of the Stuff That Fascinates People While They're Tripping On LSD - VICE - January 18th, 2020
- Rats on DMT hint at the benefits of psychedelic microdosing - Inverse - December 31st, 2019
- BEYOND LOCAL: Would you ever consider psychedelics to treat PTSD? - SooToday.com - December 31st, 2019
- A Trailblazer of Global Consciousness: Ram Dass Led the Way - Psychology Today - December 31st, 2019
- The Psychedelic Renaissance and the importance of drug policy reform - Open Access Government - December 13th, 2019
- Magic Mushrooms Move Closer to Mainstream Medicine As VC-Backed Compass Touts Safety, Positive Mood Alteration - Karma - December 13th, 2019
- Miami Clinics Use Ketamine IV Therapy to Help Treat Depression and PTSD - Miami New Times - December 13th, 2019
- Andy Frasco Talks Finding Emotional Balance With Psychedelics On 'Psychedelics Today' Podcast [Listen] - Live for Live Music - November 30th, 2019
- Will psychedelics be available commonly in the near future? - BPhrm Dv - November 30th, 2019
- Letters to the Editor: Psychedelics on their way - Valley Advocate - November 30th, 2019
- Scientists Have a Fascinating New Map of the Human Brain on DMT - VICE - November 30th, 2019
- Hes a fungi: U.S. health agency asks researcher to give it the lowdown on psilocybin mushrooms - The GrowthOp - November 30th, 2019
- A Magic Mushroom Test Case, and the Man Behind It - OZY - November 30th, 2019
- The Two Black Women Helping To Reclaim & Encourage Natural Psychedelics Use In Oakland - Okayplayer - November 2nd, 2019
- Molecule Catalyst and UTM to crowdfund psychedelics research with blockchain - Decrypt - November 2nd, 2019
- On writing: What illuminates a story? - Big Think - November 2nd, 2019
- The future of psychedelic science - Varsity - October 20th, 2019
- Psychedelic Drugs: Researchers experimenting with active agent in magic mushrooms to treat addiction, depression and anxiety - 60 Minutes - CBS News - October 17th, 2019
- Investors hope psychedelics are the new cannabis. Are they high? - The Economist - October 17th, 2019
- Mind Trip: Psychedelics Fighting Depression, Anxiety, Addiction - The National Herald - October 17th, 2019
- Devon Welsh on Growing a Mustache, Psychedelics, and Other Complicated Things - Interview - October 17th, 2019
- Roland Griffiths: 5 Fast Facts You Need to Know - Heavy.com - October 17th, 2019
- How Mushrooms Became Magic - The Atlantic - August 25th, 2017
- Using Mushrooms and LSD to Enhance Creativity - How to Use ... - August 20th, 2017
- LSD - Psychedelics - August 16th, 2017
- This Philosopher Thinks Psychedelic Drugs Lead to the Truth of Experience - Big Think - August 16th, 2017
- Can Psychedelics Treat Bipolar Disorder? - August 13th, 2017
- The foundation of Western philosophy is probably rooted in psychedelics - Quartz - August 13th, 2017
- Psychedelic drugs saved my life. So why aren't they prescribed? - Wired.co.uk - August 8th, 2017
- Daniel Greig, Canadian Drug Policy, Responsibilities, and Psychedelics - The Good Men Project (blog) - August 6th, 2017
- THE FUTURE OF PSYCHEDELICS: Are LSD and Mushrooms The New Prozac? - Dope Magazine - August 5th, 2017
- Gonzo Nieto, Drug Policy, Medical and Psychological Effects - The Good Men Project (blog) - August 3rd, 2017
- For children, it's beyond psychedelics - The Hans India - The Hans India - August 1st, 2017
- Modern psychedelic science is reviving lost research and finding new cures - The Plaid Zebra (blog) - August 1st, 2017
- Expanding consciousness - 48 Hills - August 1st, 2017